awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34787422-1C34C2B7-0941-43EA-A5B5-F928499B8670
Q34787422-1C34C2B7-0941-43EA-A5B5-F928499B8670
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34787422-1C34C2B7-0941-43EA-A5B5-F928499B8670
Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo
P2860
Q34787422-1C34C2B7-0941-43EA-A5B5-F928499B8670
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34787422-1C34C2B7-0941-43EA-A5B5-F928499B8670
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d1339e252e6cb0a8cbd4dff0931a9bf3a89814f
P2860
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.